Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Dr. Richard Paulson is a world-renowned reproductive endocrinologist and infertility specialist. He is a professor of obstetrics and gynecology and the former Director of the Division of Reproductive Endocrinology and Infertility at the University of Southern California's Keck School of Medicine. With a career spanning over three decades, Dr. Paulson is a leading authority on reproductive aging, oocyte donation, and the impact of hormones on the brain and behavior. His groundbreaking research has fundamentally changed the understanding of the limits of female reproductive potential, demonstrating that the age of the uterus is not a barrier to successful pregnancy. He is a past president of the American Society for Reproductive Medicine (ASRM) and has authored hundreds of scientific papers and book chapters, solidifying his reputation as a pivotal figure in modern reproductive medicine.
Richard Paulson's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Led groundbreaking research in the early 1990s demonstrating that the age-related decline in female fertility is due to the oocyte (egg) and not the uterus. This work proved that uteruses of postmenopausal women could successfully carry pregnancies with donor eggs, paving the way for oocyte donation as a standard treatment for age-related infertility.
Served as President of the ASRM from 2015 to 2016, the premier organization for professionals in reproductive medicine in the United States. His leadership role underscored his significant influence and standing within the global reproductive science community.
Gained international recognition for reporting the successful pregnancy and delivery in a 63-year-old woman through IVF using a donor egg, which was the oldest successful pregnancy on record at the time. This case highlighted the clinical application of his research on uterine aging and pushed the boundaries of assisted reproductive technology.
University of Toronto - Rotman School of Management - Year 1994
University of Saskatchewan - Year 1986
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Karyopharm Therapeutics is a commercial-stage pharmaceutical company pioneering novel cancer therapies. The company is dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other major diseases. Karyopharm's lead compound, XPOVIO® (selinexor), is an oral Selective Inhibitor of Nuclear Export (SINE) compound approved in the U.S. for the treatment of multiple myeloma and diffuse large B-cell lymphoma. Their core mission is to target the fundamental mechanisms of cancer to provide new treatment options for patients with high unmet medical needs.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.